Fusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients

NCT03246009 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-induced Neutropenia
Cancer, Breast

Interventions

DRUG: rHSA/GCSF
DRUG: rHSA/GCSF
DRUG: rHSA/GCSF
DRUG: rHSA/GCSF
DRUG: rHSA/GCSF
DRUG: rHSA/GCSF

Sponsor

Tianjin SinoBiotech Ltd.